These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 31970738)

  • 21. Early Small Creatinine Shift Predicts Contrast-Induced Acute Kidney Injury and Persistent Renal Damage after Percutaneous Coronary Procedures.
    Benini A; Scarsini R; Pesarini G; Pighi M; Ferrero V; Gambaro A; Piccoli A; Marin F; Inciardi RM; Gambaro G; Lupo A; Ribichini F
    Cardiovasc Revasc Med; 2020 Mar; 21(3):305-311. PubMed ID: 31204242
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Random forest for prediction of contrast-induced nephropathy following coronary angiography.
    Liu Y; Chen S; Ye J; Xian Y; Wang X; Xuan J; Tan N; Li Q; Chen J; Ni Z
    Int J Cardiovasc Imaging; 2020 Jun; 36(6):983-991. PubMed ID: 32285318
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Acute Kidney Injury After Primary Angioplasty: Is Contrast-Induced Nephropathy the Culprit?
    Caspi O; Habib M; Cohen Y; Kerner A; Roguin A; Abergel E; Boulos M; Kapeliovich MR; Beyar R; Nikolsky E; Aronson D
    J Am Heart Assoc; 2017 Jun; 6(6):. PubMed ID: 28647690
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Combined impact of chronic kidney disease and contrast-induced nephropathy on long-term outcomes in patients with ST-segment elevation acute myocardial infarction who undergo primary percutaneous coronary intervention.
    Nakahashi H; Kosuge M; Sakamaki K; Kiyokuni M; Ebina T; Hibi K; Tsukahara K; Iwahashi N; Kuji S; Oba MS; Umemura S; Kimura K
    Heart Vessels; 2017 Jan; 32(1):22-29. PubMed ID: 27106917
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Coronary artery calcification scores improve contrast-induced nephropathy risk assessment in chronic kidney disease patients.
    Osugi N; Suzuki S; Shibata Y; Tatami Y; Harata S; Ota T; Hayashi M; Yasuda Y; Ishii H; Shimizu A; Murohara T
    Clin Exp Nephrol; 2017 Jun; 21(3):391-397. PubMed ID: 27339445
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of intravascular ultrasound-guided minimum-contrast coronary intervention on 1-year clinical outcomes in patients with stage 4 or 5 advanced chronic kidney disease.
    Sakai K; Ikari Y; Nanasato M; Umetsu H; Okutsu M; Takikawa T; Sumitsuji S; Sadamatsu K; Takada M; Kato Y; Ogasawara N; Otowa K
    Cardiovasc Interv Ther; 2019 Jul; 34(3):234-241. PubMed ID: 30343351
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ultra-Low Contrast Volume for Patients with Advanced Chronic Kidney Disease Undergoing Coronary Procedures.
    Rozenbaum Z; Benchetrit S; Rozenbaum E; Neumark E; Mosseri M; Pereg D
    Nephron; 2018; 138(4):296-302. PubMed ID: 29393219
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Circulating tumour necrosis factor receptors 1 and 2 predict contrast-induced nephropathy and progressive renal dysfunction: a prospective cohort study.
    An JN; Yoo KD; Hwang JH; Kim HL; Kim SH; Yang SH; Kim JH; Kim DK; Oh YK; Kim YS; Lim CS; Lee JP
    Nephrology (Carlton); 2015 Aug; 20(8):552-9. PubMed ID: 25783484
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A case of CTO treated with minimum use of contrast media.
    Uehara Y; Shimizu M; Yoshimura M
    Catheter Cardiovasc Interv; 2013 Dec; 82(7):E884-7. PubMed ID: 23359535
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Contrast induced acute kidney injury in interventional cardiology: an update and key guidance for clinicians.
    Ronco F; Tarantini G; McCullough PA
    Rev Cardiovasc Med; 2020 Mar; 21(1):9-23. PubMed ID: 32259900
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Left ventricular end diastolic pressure and contrast-induced acute kidney injury in patients with acute coronary syndrome undergoing percutaneous coronary intervention.
    Lima FV; Singh S; Parikh PB; Gruberg L
    Cardiovasc Revasc Med; 2018 Sep; 19(6S):16-20. PubMed ID: 29929842
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Statins and contrast-induced acute kidney injury with coronary angiography.
    Gandhi S; Mosleh W; Abdel-Qadir H; Farkouh ME
    Am J Med; 2014 Oct; 127(10):987-1000. PubMed ID: 24852935
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association Between Contrast Media Volume-Glomerular Filtration Rate Ratio and Contrast-Induced Acute Kidney Injury After Primary Percutaneous Coronary Intervention.
    Celik O; Ozturk D; Akin F; Ayca B; Yalcın AA; Erturk M; Bıyık I; Ayaz A; Akturk IF; Enhos A; Aslan S
    Angiology; 2015 Jul; 66(6):519-24. PubMed ID: 25005762
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Risk of contrast-induced nephropathy in patients undergoing complex percutaneous coronary intervention.
    Azzalini L; Poletti E; Lombardo F; Laricchia A; Beneduce A; Moscardelli S; Bellini B; Maccagni D; Cappelletti A; Ancona MB; Carlino M; Chieffo A; Colombo A; Montorfano M
    Int J Cardiol; 2019 Sep; 290():59-63. PubMed ID: 31005417
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic of different glomerular filtration rate formulas in patients receiving percutaneous coronary intervention: insights from a multicenter observational cohort.
    Chen W; Chen P; Ni Z; Liu Y; Guo W; Jiang L; Wei X; Chen J; Tan N; He P; Guo Y
    BMC Cardiovasc Disord; 2020 Jul; 20(1):341. PubMed ID: 32682399
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A Randomized Trial of Recombinant Human C1-Esterase-Inhibitor in the Prevention of Contrast-Induced Kidney Injury.
    Panagiotou A; Trendelenburg M; Heijnen IAFM; Moser S; Bonati LH; Breidthardt T; Fahrni G; Kaiser C; Jeger R; Osthoff M
    JACC Cardiovasc Interv; 2020 Apr; 13(7):833-842. PubMed ID: 32171721
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Zero contrast optical coherence tomography-guided percutaneous coronary intervention in patients with non-ST segment elevation myocardial infarction and chronic kidney disease.
    Liu ZY; Yin ZH; Liang CY; He J; Wang CL; Peng X; Zhang Y; Zheng ZF; Pan HW
    Catheter Cardiovasc Interv; 2021 May; 97 Suppl 2():1072-1079. PubMed ID: 33764682
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differential Clinical Outcomes Between Angiographic Complete Versus Incomplete Coronary Revascularization, According to the Presence of Chronic Kidney Disease in the Drug-Eluting Stent Era.
    Kim J; Lee JM; Choi KH; Rhee TM; Hwang D; Park J; Ahn C; Park TK; Yang JH; Song YB; Choi JH; Hahn JY; Choi SH; Gwon HC
    J Am Heart Assoc; 2018 Feb; 7(4):. PubMed ID: 29449272
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Safety margin of minimized contrast volume during percutaneous coronary intervention in patients with chronic kidney disease.
    Ogata N; Ikari Y; Nanasato M; Okutsu M; Kametani R; Abe M; Uehara Y; Sumitsuji S
    Cardiovasc Interv Ther; 2014 Jul; 29(3):209-15. PubMed ID: 24474044
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Guideline on the use of iodinated contrast media in patients with kidney disease 2018.
    Isaka Y; Hayashi H; Aonuma K; Horio M; Terada Y; Doi K; Fujigaki Y; Yasuda H; Sato T; Fujikura T; Kuwatsuru R; Toei H; Murakami R; Saito Y; Hirayama A; Murohara T; Sato A; Ishii H; Takayama T; Watanabe M; Awai K; Oda S; Murakami T; Yagyu Y; Joki N; Komatsu Y; Miyauchi T; Ito Y; Miyazawa R; Kanno Y; Ogawa T; Hayashi H; Koshi E; Kosugi T; Yasuda Y;
    Clin Exp Nephrol; 2020 Jan; 24(1):1-44. PubMed ID: 31709463
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.